Pure Global
NCT06020222

The Effect of Cryotherapy on Breast Cancer Patients

The Effect of Cryotherapy on Breast Cancer Patients in Kaohsiung Medical University Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Chemotherapy-induced Peripheral Neuropathy
Drug/Device/Intervention
cryotherapy
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Location
Kaohsiung, Taiwan
Timeline & enrollment
Phase
N/A
Start date
May 01, 2023
End date
Dec 31, 2024
Enrollment
94 participants
Primary outcome

Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ),Patient neurotoxicity questionnaire (PNQ)

Summary

The goal of this clinical trial is to test the effect of cryotherpay on chemotherapy-induced
 peripheral neuropathy(CIPN) among Breast Cancer Patients. The main questions of research are:
 
 - Does cryotherapy reduce the incidence of CIPN?
 
 - Does cryotherapy reduce the severity of CIPN and improve the quality of life?
 Participants will be put on the cold gloves and boots during chemotherapy injection
 process and total 90 minutes.
 
 If there is a comparison group: Researchers will compare usual care group to make sure if it
 effects of CIPN.

ICD-10 classifications
Drug-induced polyneuropathyParaneoplastic neuromyopathy and neuropathyPolyneuropathy due to other toxic agentsIdiopathic peripheral autonomic neuropathyIdiopathic progressive neuropathy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06020222
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06020222 through Pure Global AI's free database. This phase not specified trial is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital and is currently Recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 94 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.